|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 143.00 GBX | +0.35% |
|
0.00% | +11.72% |
| 06-02 | Diaceutics PLC, 2025 Earnings Call, May 26, 2026 | |
| 05-26 | Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 3.06x | - | 2.89x | 14.99x | 112.01x | -.--% | 162M | |
| -163.31x | 10.85x | 0.56x | 24.25x | 58.25x | -103.13x | -.--% | 67.88B | |
| 38.62x | 4.2x | 0.5x | 2.95x | 23.41x | 37.58x | 1.14% | 4.31B | |
| 107.25x | 6.49x | 1.9x | 13.42x | 19.57x | 117.38x | 0.29% | 3.39B | |
| 41.33x | 15.39x | 58.78x | 12.63x | 28.23x | 32.71x | 1.69% | 2.07B | |
| -26.72x | 3.86x | 0.47x | - | - | - | 0.1% | 1.31B | |
| 41.14x | 8.33x | 1.29x | 16.97x | 26.33x | 28.9x | 0.56% | 1.22B | |
| 15.36x | 4.53x | 0.39x | - | - | - | 0.38% | 1.15B | |
| 24.58x | 2.13x | 31.57x | 3.85x | 13.85x | 17.11x | 0.67% | 1.12B | |
| -1.93x | - | 0.24x | 5.1x | 8.34x | 96.45x | -.--% | 523M | |
| 26.86x | 3.17x | 2.96x | 2.75x | 8.41x | 13.81x | - | 164M | |
| -58.72x | 4.78x | 0.66x | 1.6x | 12.35x | -40.54x | - | 131M | |
| Average | 4.04x | 6.07x | 9.03x | 8.64x | 21.37x | 31.23x | 0.48% | 6.95B | |
| Weighted average by Cap. | -125.03x | 10.04x | 2.49x | 21.73x | 52.33x | -77.21x | 0.14% |
- Stock Market
- Stocks
- DXRX Stock
- Sector Diaceutics PLC
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
